Clinical Trial Update: A Study to Evaluate the Long-term Safety, Pharmacodynamics and Efficacy of SHR-1703 in Eosinophilic Asthma Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial to evaluate the long-term safety, pharmacodynamics, and efficacy of SHR-1703 in patients with eosinophilic asthma, currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Eosinophilic Asthma

Drugs mentioned

• SHR-1703

Snippet

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd | Conditions: Eosinophilic Asthma Patients | Phase 2 | Status: RECRUITING